Consumer Staples • Retail-Drug Stores and Proprietary Stores
$40.45 ▲ +0.12
(+0.30%)
MKT CAP: $2.56B • VOL: 208.0K
52W L $26 52W H $48
GRDN // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 |
|---|---|---|
| Revenue (Total Sales) | $1.45B | $1.23B |
| YoY Revenue Growth % | +17.9% | — |
| Gross Profit | $292.7M | $244.4M |
| Gross Margin % | 20.2% | 19.9% |
| Research & Development (R&D) | — | — |
| Operating Income (EBIT) | $72.7M | -$62.9M |
| Operating Margin % | 5.0% | -5.1% |
| Net Income (GAAP) | $49.2M | -$110.0M |
| EBITDA (Normalized) | — | — |
| Diluted EPS ($/sh) | — | — |
| Operating Cash Flow (OCF) | $100.3M | $58.0M |
| Capital Expenditures (CapEx) | — | — |
| Free Cash Flow (FCF) | $100.3M | $58.0M |
| FCF Margin % | 6.9% | 4.7% |
| Return on Invested Capital (ROIC %) | 37.7% | -34.2% |
| Cash & Short-Term Equivalents | $65.6M | $4.7M |
| Total Debt (Short + Long Term) | — | — |
| Total Stockholders' Equity | $217.9M | $150.0M |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR GRDN.